Banned drugs: The Government of India, vide notifications published in the Gazette of India vide G.S.R. No. 578 (E) dated 23/07/1983 and subsequent amendments, made under Section 26 A of Drugs and Cosmetics Act, 1940 has prohibited the manufacture, sale, and distribution of the following categories of fixed dose combinations that do not have any therapeutic justification or are likely to involve a risk to human beings:
Download the latest notifications on Banned drugs: Govt. of India issues From time to time, notifications are published by the Department of Publication and printed by the Government of India Printing Presses regularly.
We have provided some of the important notifications relevant to the above-mentioned topic, Click on the below links for more information:
List of drugs prohibited for manufacture and sale by the Ministry of Health and Family Welfare via gazette notifications under Section 26a of the Drugs and Cosmetics Act 1940, with their current status as of November 22, 2021
Sr. No.
Drugs Name
Notification No. & Date
1.
Amidopyrine.
GSR NO. 578(E) Dated 23.07.1983
2.
Fixed dose combinations of vitamins with anti- inflammatory agents and tranquilizers.
GSR NO. 578(E) Dated 23.07.1983
3.
Fixed dose combinations of Atropine in Analgesics and Antipyretics.
GSR NO. 578(E) Dated 23.07.1983
4.
Fixed dose combinations of Strychnine and Caffeine in tonics.
GSR NO. 578(E) Dated 23.07.1983
5.
Fixed dose combinations of Yohimbine and Strychnine with Testosterone and Vitamins.
GSR NO. 578(E) Dated 23.07.1983
6.
Fixed dose combinations of Iron with Strychnine, Arsenic and Yohimbine.
GSR NO.578(E) Dated 23.07.1983
7.
Fixed dose combinations of Sodium Bromide/chloral hydrate with other drugs.
GSR NO.578(E) Dated 23.07.1983
8.
Phenacetin.
GSR NO. 578(E) Dated 23.07.1983
9.
Fixed dose combinations of antihistaminic with anti-diarrhoeals.
GSR NO.578(E) Dated 23.07.1983
10.
Fixed dose combinations of Penicillin with Sulphonamides.
GSR NO. 578(E) Dated 23.07.1983
11.
Fixed dose combinations of Vitamins with Analgesics.
GSR NO. 578(E) Dated 23.07.1983
12.
Fixed dose combinations of any other Tetracycline With Vitamin C.
GSR NO. 578(E) Dated 23.07.1983
13.
Fixed dose combinations of Hydroxyquinoline group of drugs with any other drug except for preparations meant for external use.
Substituted vide GSR NO. 793(E) Dated 13.12.1995
14.
Fixed dose combinations of Chloramphenicol with any other drug for internal use.
Substituted vide GSR NO. 1057(E) Dated 03.11.1988
15.
Fixed dose combinations of crude Ergot preparations except those containing Ergotamine, Caffeine, analgesics, antihistamines for the treatment of migraine, headache.
Substituted vide GSR NO. 304 (E) Dated 07.06.1991
16.
Fixed dose combinations of Vitamins with Anti TB drugs Except combination of Isoniazid with Pyridoxine Hydrochloride (Vitamin B6).
GSR NO. 578 (E) Dated 23.07.1983
17.
Penicillin skin/eye Ointment.
GSR NO. 578 (E) Dated 23.07.1983
18.
Tetracycline Liquid Oral preparations.
GSR NO. 578 (E) Dated 23.07.1983
19.
Nialamide.
GSR NO. 578 (E) Dated 23.07.1983
20.
Practolol.
GSR NO. 578 (E) Dated 23.07.1983
21.
Methapyrilene, its salts.
GSR NO. 578(E)Dated2 3.07.1983
22.
Methaqualone.
GSR NO. 49 (E) Dated 31.01.1984
23.
Oxytetracycline Liquid Oral preparations.
GSR NO. 322 (E) Dated 03.05.1984
24.
Demeclocycline Liquid Oral preparations.
GSR NO. 322 (E) Dated 03.05.1984
25.
Combination of anabolic Steroids with other drugs.
GSR NO. 863 (E) Dated 22.11.1985
26.
Fixed dose combination of Oestrogen and Progestin (other than oral contraceptive) containing per tablet Estrogen content of more than 50mcg (equivalent to Ethinyl Estradiol) and content of more than 3 mg (equivalent to Norethisterone Acetate) and all fixed dose combination injectable preparations containing synthetic Oestrogen and Progesterone.
Substituted vide GSRNO. 743 (E) Dated 10.08.1989
27.
Fixed dose combination of Sedatives/hypnotics/anxiolytics with analgesics-antipyretics.
GSR NO. 999(E)Dated26. 12.1990
28.
Fixed dose combination of Rifampicin, isoniazid and Pyrazinamide, except those which Provide daily adult dose given below: Drugs Minimum Maximum Rifampicin 450mg 600mg Isoniazid 300mg 400mg Pyrazinamide 1000mg 1500mg
Substituted vide GSR NO.100(E) Dated 11.02.2003
29.
Fixed dose combination of Histamine H-2 receptor antagonists with antacids except for those combinations approved by Drugs Controller, India.
GSR NO. 999 (E) Dated 26.12.1990
30.
The patent and proprietary medicines of fixed dose combinations of essential oils with alcohol having percentage higher than 20% proof except preparations given in the Indian Pharmacopoeia.
GSR NO. 999 (E) Dated 26.12.1990
31.
All Pharmaceutical preparations containing Chloroform exceeding 0.5%w/w or v/v whichever is appropriate.
GSR NO. 999 (E) Dated 26.12.1990
32.
Fixed dose combination of Ethambutol with INH other than the following: INH Ethambutol 200mg. 600mg. 300mg. 800mg.
GSR NO. 69(E)Dated 11.02.1991
33.
Fixed dose combination containing more than one antihistamine.
GSR NO. 69(E)Dated 11.02.1991
34.
Fixed dose combination of any anthelmintic with cathartic/purgative except for piperazine/Santonin.
GSR NO. 69 (E) Dated 11.02.1991
35.
Fixed dose combination of Salbutamol or any other bronchodilator with centrally acting anti-tussive and/or antihistamine.
Substituted vide GSR NO. 290(E)Dated1 6.04.2008
36.
Fixed dose combination of laxatives and/or anti-spasmodic drugs in enzyme preparations.
GSR NO. 69(E)Dated 11.02.1991
37.
Fixed dose combination of Metoclopramide with systemically absorbed drugs except fixed dose combination of metoclopramide with aspirin/paracetamol
Substituted vide GSR NO. 603(E)Dated2 4.08.2001
38.
Fixed dose combination of centrally acting, antitussive with antihistamine, having high atropine like activity in expectorants.
GSR NO. 395(E)Dated 19.05.1999
39.
Preparations claiming to combat cough associated with asthma containing centrally acting antitussive and/or an antihistamine.
GSR NO. 395(E)Dated 19.05.1999
40.
Liquid oral tonic preparations containing glycerophosphates and/or other phosphates and/or central nervous system stimulant and such preparations containing alcohol more than 20% proof.
GSR NO. 395(E)Dated 19.05.1999
41.
Fixed dose combination containing Pectin and/or Kaolin with any drug which is systemically absorbed from GI tract except for combinations of Pectin and/or Kaolin with drugs not systemically absorbed.
GSR NO. 395(E)Dated 19.05.1999
42.
Chloral Hydrate as a drug.
GSR NO. 304(E)Dated 07.06.1991
43.
Dovers Powder I.P.
GSR NO. 612(E)Dated0 9.08.1994
44.
Dover’s Powder Tablets I.P.
GSR NO. 612(E)Dated0 9.08.1994
45.
Antidiarrhoeal formulations containing Kaolin or Pectin or Attapulgite or Activated Charcoal.
GSR NO. 731(E)Dated 30.09.1994
46.
Antidiarrhoeal formulations containing Phthalyl Sulphathiazole or Sulphaguanidine or Succinyl Sulphathiazole.
GSR NO. 731(E)Dated3 0.09.1994
47.
Antidiarrhoeal formulations containing Neomycin or Streptomycin or Dihydrostreptomycin including their respective salts or esters.
GSR NO. 731(E)Dated3 0.09.1994
48.
Liquid Oral antidiarrhoeals or any other dosage form for pediatric use containing Diphenoxylate L or loperamide or Atropine or Belladona including their salts or esters or Metabolites Hyoscyamine or their extracts or their alkaloids.
GSR NO. 731(E)Dated3 0.09.1994
49.
Liquid Oral antidiarrhoeals or any other dosage form for pediatric use containing halogenated hydroxyquinolines.
GSR NO. 731(E)Dated3 0.09.1994
50.
Fixed dose combination of antidiarrhoeals with electrolytes.
GSR NO. 731(E)Dated 30.09.1994
51.
Patent and Proprietary Oral Rehydration Salts other than those conforming to the following parameters: Patent and Proprietary oral rehydration salts on reconstitution to one litre shall contain: Sodium–50to90milliosmoles Total osmolarity–240-290 millios moles Dextrose: Sodium molar ratio–Not less than 1:1 and not morethan3:1 Patent and proprietary cereal based oral rehydration salts on reconstitution to one litre shall contain: Sodium–50 to 90 millios moles Total osmolarity–Not morethan 290 millios moles Precooked rice–equivalent to not less than 50gms and not more than 80gms as total replacement of dextrose
GSR NO. 57(E) Dated07.02 .1995
Patent and proprietary oral rehydration salts (ORS) may contain amino acids in addition to oral rehydration salts conforming to the parameters specified above and labelled with the indication for “Adult Chloretic Diarrhea Only”Patent and proprietary oral rehydration salts (ORS) shall Not contain mono or polysaccharides or saccharin sweetening agent.
52.
Fixed dose combination of Oxyphenbutazone or Phenyl butazone with any other drug.
GSRNO. 633(E) Dated 13.09.1995
53.
Fixed dose combination of Analgin with any other drug.
GSR NO. 405 (E) Dated 03.06.1996
54.
Fixed dose combination of dextropropoxyphene with any other Drug other than anti-spasmodics and/or non-steriodal anti- inflammatory drugs (NSAIDS).
GSR NO. 633(E)Dated1 3.09.1995
55.
Fixed dose combination of a drug, standards of which are Prescribed in the Second Schedule to the said Act with an Ayurvedic, Siddha or Unani drug.
GSR NO. 633 (E) Dated 13.09.1995
56.
Mepacrine Hydrochloride (Quinacrine and its salts) in any dosage form for use for female sterilization or contraception.
GSR NO. 499 (E) Dated 14.08.1998
57.
Fenfluramine
GSR NO. 499 (E) Dated 14.08.1998
58.
Dexfenfluramine.
GSR NO. 499 (E) Dated 14.08.1998
59.
Fixed dose combination of Diazepam and Diphenhydramine Hydrochloride.
GSR NO. 169 (E) Dated 12.03.2001
60.
Cosmetics Licensed as toothpaste/tooth powder containing tobacco.
GSR NO. 444 (E) Dated 30.04.1992
61.
Parenteal Preparations fixed combination of streptomycin with Pencillin
GSR NO. 93 (E) Dated 25.02.1997
62.
Fixed dose combination of Vitamin B1 Vitamin B6 and Vitamin B12 for human use
GSR NO. 702 (E) Dated 14.10.1999
63.
Fixed dose combination of haemoglobin in any form (natural or synthetic).
GSR NO. 814 (E) Dated 16.12.1999
64.
Fixed dose combination of Pancreatin or Pancrelipase containing amylase, protease and lipase with any other enzyme.
GSR NO. 814 (E) Dated 16.12.1999
65.
Fixed dose combination of Nitrofurantoin and trimethoprim.
GSR NO. 170 (E) Dated 12.03.2001
66.
Fixed dose combination of Phenobarbitone with any anti- asthmatic drugs.
GSR NO. 170(E)Dated 12.03.2001
67.
Fixed dose combination of Phenobarbitone with Hyoscin and/or Hyoscyamine
GSR NO. 170(E)Dated 12.03.2001
68.
Fixed dose combination of Phenobarbitone with Ergotamine and/or Belladona
GSR NO. 170(E)Dated 12.03.2001
69.
Fixed dose combination of Haloperidol with any anti- cholinergic agent including Propantheline Bromide.
GSR NO. 170(E)Dated 12.03.2001
70.
Fixed dose combination of Nalidixic Acid with any anti-amoebic including Metronidazole.
GSR NO. 170(E)Dated 12.03.2001
71.
Fixed dose combination of Loperamide Hydrochloride with Furazolidone
GSR NO. 170(E)Dated 12.03.2001
72.
Fixed dose combination of Cyproheptadine with Lysine or Peptone.
GSR NO. 170(E)Dated 12.03.2001
73.
Astemizole
GSR NO. 191(E)Dated0 5.03.2003
74.
Terfinadine
GSR NO. 191(E)Dated 05.03.2003
75.
Phenformin
GSR NO. 780 (E) Dated 01.10.2003
76.
Rofecoxib and its formulations
GSR NO. 810(E)Dated 13.12.2004
77.
Valdecoxib and its formulations
GSR NO. 510(E)Dated 28.07.2005
78.
Diclofenac and its formulations (for animal use)
GSR NO. 499(E)Dated 04.07.2008
79.
Rimonabant.
GSRNO.884 (E) Dated 11.12.2009
80.
Rosiglitazone
GSR NO. 910 (E) Dated 12.11.2010
81.
Nimesulide formulations for human use in children below 12years of age.
GSR NO. 82 (E) Dated 10.02.2011
82.
Cisapride and its formulations for human use.
GSR NO. 82 (E) Dated 10.02.2011
83. 1#
Phenypropanol amine and its formulations for human use.
GSR NO. 82 (E) Dated 10.02.2011
84.
Human Placental Extract and its formulations for human use except its Topical application for wound healing, andInjection for pelvic inflammatory disease.
Substituted vide GSR NO. 418 (E)Dated 30.05.2011
85.
Sibutramine and its formulations for human use.
GSR NO. 82(E) Dated 10.02.2011
86.
R-Sibutramine and its formulations for human use.
GSR NO. 82(E) Dated 10.02.2011
87.
“Gatifloxacin formulation for systemic use in human by any route including oral and injectable”.
GSR NO. 218(E) Dated 16.03.2011
88.
Tegaserod and its formulations
GSR NO. 218(E) Dated 16.03.2011
89.
Letrozole for induction of ovulation in anovulatory infertility.
GSR NO. 752(E) Dated 12.10.2011
90.
Serodiagnostic test kits for diagnosis of tuberculosis
Dextropropoxyphene and formulations containing Dextropropoxyphene for human use
G.S.R.332 (E) dated 23.5.2013
92.
Pioglitazone and all formulations containing Pioglitazone for human use
Initial suspension vide G.S.R.No. 379 (E) dt 18- 6-2013
93.
Fixed dose combination of Flupenthixol +Melitracen for human use
G.S.R.377 (E) dated 18.6.2013 and 498 (E) Dated 11.07.2014
94.
Analgin and all formulations containing analgin for human use
Initial Suspension vide G.S.R. No 378 (E) dated 18.6.2013 Was revoked allowing the use of drug with certain condition vide G.S.R. No.86 (E) dated 13.2.2014 Was revoked allowing the use of drug with certain condition vide [G.S.R. No.520 (E) dt 31-7- 2013
Fixed dose combinations of Corticosteroids with any other drug [excluding Fixed Dose Combination of Tamsulosin HCl 0.4mg (as film coated modified release tablet) + Deflazacort 30mg in hard gelatin capsule] for internal use except for preparations meant for meter dose inhalers and dry powder inhalers.
Substituted vide GSR NO. 255(E) Dated 07.04.2021
1# Presently stayed by the Hon’ble High Court of Madras.
2# Prohibition was revoked with following conditions vide G.S.R. No. 367 (E) dated 13.04.2017: –
The manufacturer shall indicate in a conspicuous manner on the package-inserts and promotional literature of the dextropropoxyphene and its formulations: –
“Use of drug for cancer pain only”, and
“Daily administered dose shall not exceed 300mg. per day”.
The container of the medicine containing dextropropoxyphene shall be labeled with the following words: –
Use of drug for cancer pain only”, and
“Daily administered dose shall not exceed 300 mg per day”
The manufacturer shall advise the registered medical practitioners to administer or prescribe the said drug and its formulations for use in patients with cancer pain only.
3# As per Hon’ble Supreme Court order dated 15.12.2017, the list of 15 FDCs were claimed prior to 1988. The matter is still under examination in consultation with Expert Committee.
4# As per Hon’ble Supreme Court order dated 14.02.2019, the list of 04 FDCs were claimed prior to 1988. The matter is still under examination in consultation with Expert Committee.
5# The notification of S.O. No. 705 (E) dated 10.03.2016 [S.O. No. 4379 (E) dated 07.09.2018] was quashed by Hon’ble Delhi High Court vide its order dated 13.03.2019. The CDSCO has filed an appeal against the order dated March 13, 2019, and the matter is sub judice.
The Notification of S.O. No. 760 (E) dated 10.03.2016 [S.O. No. 4429 (E) dated 07.09.2018] was quashed by Hon’ble Delhi High Court vide its order dated 18.02.2019 The CDSCO has filed an appeal against the order dated 18.02.2019 and the matter is sub judice.
The Notification of S.O. No. 806 (E) dated 10.03.2016 [S.O. No. 4471 (E) dated 07.09.2018] & S.O. No. 807 (E) dated 10.03.2016 [S.O. No. 4472 (E) dated 07.09.2018] were quashed by Hon’ble Delhi High Court vide its order dated 13.02.2019. The CDSCO has filed an appeal against the order dated 13.03.2019 and the matter is sub judice.
The Notification of S.O. No. 814 (E) dated 10.03.2016 [S.O. No. 4479 (E) dated 07.09.2018] was quashed by Hon’ble Delhi High Court vide its order dated 22.02.2019. The CDSCO has filed an appeal against the order dated 22.02.2019 and the matter is sub judice.
The notification of S.O. No. 1855 (E) dated 08.06.2017 [S.O. No. 4706 (E) dated 07.09.2018] pertaining to FDC of S(+) Etodolac + Paracetamol was quashed by the Hon’ble Delhi High Court vide its order dated 22.01.2020.
Note: The above list of prohibited drugs is prepared as per the records available with this office.
If discrepancy is observed, the same may be brought to the notice of this office along with documentary evidence for necessary action.